Anti-HER3 monoclonal antibody patritumab sensitizes refractory non-small cell lung cancer to the epidermal growth factor receptor inhibitor erlotinib

K. Yonesaka, K. Hirotani, H. Kawakami, M. Takeda, H. Kaneda, K. Sakai, I. Okamoto, K. Nishio, P. A. Jänne, K. Nakagawa

Research output: Contribution to journalArticlepeer-review

64 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Anti-HER3 monoclonal antibody patritumab sensitizes refractory non-small cell lung cancer to the epidermal growth factor receptor inhibitor erlotinib'. Together they form a unique fingerprint.

Medicine & Life Sciences